Home › Myeloproliferative Neoplasms › Maine › West Scarborough
Myeloproliferative Neoplasms clinical trials in West Scarborough, ME
4 studies for Myeloproliferative Neoplasms are looking for participants at sites in and around West Scarborough (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecruitingPhase 2
- MaineHealth Maine Medical Center- Scarborough, Scarborough · 3 mi away
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecruitingPhase 2
- MaineHealth Maine Medical Center- Scarborough, Scarborough · 3 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Maine Children's Cancer Program, Scarborough · 3 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Scarborough · 3 mi away
Myeloproliferative Neoplasms trials in other cities
- Houston, TX16 studies
- New York City, NY15 studies
- Boston, MA14 studies
- Milwaukee, WI10 studies
- Miami, FL10 studies
- Durham, NC9 studies
- Baldwin Park, CA9 studies
- Seattle, WA9 studies
- Chicago, IL9 studies
- Portland, OR8 studies
- Cleveland, OH8 studies
- Atlanta, GA8 studies
Other studies in West Scarborough
- Ovarian Cancer9 studies
- Acute Myeloid Leukemia9 studies
- Breast Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Lung Cancer7 studies
- Endometrial Cancer6 studies
- Metastatic Cancer5 studies
- Cancer (all types)4 studies
- Burkitt Lymphoma4 studies
- Colon Cancer4 studies
- Prostate Cancer4 studies
- Melanoma4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.